These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 17394152

  • 1. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

  • 2. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C.
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [Abstract] [Full Text] [Related]

  • 3. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT.
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.
    Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP.
    Liver Transpl; 2002 Sep; 8(9):765-74. PubMed ID: 12200775
    [Abstract] [Full Text] [Related]

  • 6. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA.
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [Abstract] [Full Text] [Related]

  • 7. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 8. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC, Molmenti EP, Omar OS, Bockhorn M, Brokalaki EI, Lang H, Frilling A, Broelsch CE, Malagó M.
    Eur J Med Res; 2006 Nov 30; 11(11):467-70. PubMed ID: 17182358
    [Abstract] [Full Text] [Related]

  • 10. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW.
    Ann Surg; 2007 Sep 30; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria.
    Suh KS, Cho EH, Lee HW, Shin WY, Yi NJ, Lee KU.
    Dig Dis; 2007 Sep 30; 25(4):329-33. PubMed ID: 17960068
    [Abstract] [Full Text] [Related]

  • 12. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan 30; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM.
    Liver Transpl; 2004 Jul 30; 10(7):911-8. PubMed ID: 15237377
    [Abstract] [Full Text] [Related]

  • 14. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec 30; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 15. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T, Gheza F, Ellero B, Woehl-Jaegle ML, Ntourakis D, Cantu M, Marzano E, Audet M, Wolf P, Pessaux P.
    Ann Surg Oncol; 2012 Jun 30; 19(6):2020-6. PubMed ID: 22179632
    [Abstract] [Full Text] [Related]

  • 16. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU.
    Surgery; 2007 May 30; 141(5):598-609. PubMed ID: 17462459
    [Abstract] [Full Text] [Related]

  • 17. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW.
    Clin Transplant; 2007 May 30; 21(6):696-701. PubMed ID: 17988261
    [Abstract] [Full Text] [Related]

  • 18. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar 30; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH, Ho MC, Wu YM, Yu SC, Lee PH.
    Clin Transplant; 2005 Apr 30; 19(2):175-80. PubMed ID: 15740552
    [Abstract] [Full Text] [Related]

  • 20. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.
    Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, Ko GY, Park KM, Ha TY, Song GW.
    Liver Transpl; 2008 Jul 30; 14(7):935-45. PubMed ID: 18581465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.